This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Michael Tomsicek, Cubist CFO (Photo: Business Wire)

Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced the appointment of Michael Tomsicek as Senior Vice President and Chief Financial Officer (CFO). Mr. Tomsicek, who has served as Senior Vice President and Deputy CFO since July 2012, succeeds David McGirr. After more than a decade of leadership at Cubist, Mr. McGirr will serve as Senior Advisor to the Chief Executive Officer (CEO), and retire in 2014.
Michael Tomsicek, Cubist CFO (Photo: Business Wire)

Michael Tomsicek, Cubist CFO (Photo: Business Wire)

“David has been an outstanding contributor to Cubist’s success over the past decade,” said Mike Bonney, Cubist’s CEO. "He helped build the strong financial foundation that Cubist and our shareholders benefit from today. We appreciate his dedication to Cubist and are pleased he will continue to serve the Company during this time of transition. In addition, a critical component of our Building Blocks of Growth strategic goals has been cultivating top talent, and we are very fortunate to have a successor in Michael who can step into this important role and help continue our excellent momentum as we begin our next chapter as a Company.”

Mr. McGirr said, "I’ve enjoyed working closely with Mike and everyone at Cubist as CFO over the past decade and am proud to have helped the Company become a global leader in the hospital and acute care environment, help countless patients, and generate significant value for shareholders. I believe now is the right time for a transition and am confident Michael will serve Cubist very well as our CFO.”

“I have been fortunate to work closely with David to ensure a smooth transition into my expanded role,” said Mr. Tomsicek. “With a strong financial foundation, an exceptional late-stage pipeline, and an emerging global presence, this is an exciting time at Cubist. I look forward to helping the Company continue to grow and expand in the years ahead.”

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $94.19 0.00%
FB $118.06 0.00%
GOOG $695.70 0.00%
TSLA $222.56 0.00%
YHOO $36.00 0.00%


Chart of I:DJI
DOW 17,651.26 -99.65 -0.56%
S&P 500 2,051.12 -12.25 -0.59%
NASDAQ 4,725.6390 -37.5850 -0.79%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs